Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions: 2017-2024

Historic Tax Provisions for Fortress Biotech (FBIO) over the last 6 years, with Dec 2024 value amounting to $312,000.

  • Fortress Biotech's Tax Provisions fell 74.00% to $26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $841,000, marking a year-over-year decrease of 21.33%. This contributed to the annual value of $312,000 for FY2024, which is 40.12% down from last year.
  • Fortress Biotech's Tax Provisions amounted to $312,000 in FY2024, which was down 40.12% from $521,000 recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Tax Provisions registered a high of $521,000 during FY2023, and its lowest value of $136,000 during FY2020.
  • Moreover, its 3-year median value for Tax Provisions was $449,000 (2022), whereas its average is $427,333.
  • Its Tax Provisions has fluctuated over the past 5 years, first soared by 267.65% in 2021, then slumped by 40.12% in 2024.
  • Yearly analysis of 5 years shows Fortress Biotech's Tax Provisions stood at $136,000 in 2020, then skyrocketed by 267.65% to $500,000 in 2021, then fell by 10.20% to $449,000 in 2022, then rose by 16.04% to $521,000 in 2023, then slumped by 40.12% to $312,000 in 2024.